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Abstract
Diagnostic testing for the novel coronavirus is an important tool to fight the coronavirus dis-
ease (Covid-19) pandemic. However, testing capacities are limited. A modified testing proto-
col, whereby a number of probes are ‘pooled’ (i.e. grouped), is known to increase the capacity
for testing. Here, we model pooled testing with a double-average model, which we think to be
close to reality for Covid-19 testing. The optimal pool size and the effect of test errors are con-
sidered. The results show that the best pool size is three to five, under reasonable assumptions.
Pool testing even reduces the number of false positives in the absence of dilution effects.
Introduction
The fast global spread of the novel coronavirus is responsible for the current pandemic, known
as coronavirus disease 2019 (Covid-19). Diagnostic tests for the novel coronavirus (nCov) are
being employed worldwide. It is self-evident that increasing the number of diagnostic tests is
important to combat the epidemic.
Widely used tests for Covid-19 detect the novel coronavirus RNA genome, using the real-
time polymerase chain reaction method. The capacities for such tests, however, are limited by
the used reactants, machine time, lab personnel time and overall logistics. Remarkably, testing
capacities can be increased by a modification of the testing protocol.
Combining probes from several individuals and testing them together reduces the total
amount of tests needed. This method, known as pooling or group testing, has been known
for a long time [1]. The main idea is: when probes from several people are mixed together
(pooled) and tested, the test will report negative when everyone is healthy and positive
when at least one person is infected.
This study deals with Dorfman’s classic two-stage protocol [1] (described below). More
complicated procedures have been devised; however, we shall not consider them here.
The pooling method was validated for nCov tests by many laboratories [2–15]. However,
the following questions remained open, which we address in this paper. (1) What pool size
should be used? (2) How are test errors affected by the procedure?
Results
The two-stage procedure is as follows [1]. We denote the number of people in one pool, i.e. the
pool size, by M. Probes of M people are each split in two parts. One part is mixed together
with the others, while the other part is kept for later. The mixture is tested for nCov. Upon
a negative result, all the M people are declared healthy. When the result is positive, go to
the second stage. In the second stage, each of the M people is tested individually using the
probes that were put aside previously; the final test result is that of this second stage.
Pool size
Here we address the question: How many people should be pooled together?
We consider a ‘double-averaging’ model (see Methods), where the prevalence is estimated
by a minimal and maximal value. Then, the results are only weakly dependent on the precise
values, for reasonable values. Taking the prevalence to be between 0 and 30%, we have the
result that a pool size of four is optimal; see Figure 1 for other ranges. Pool sizes of three
and five give results which are close to optimal, see Figure 2 for a comparison.
Therefore, we recommend a pool size of four. Pool sizes of three or five can be used as well,
if that is more convenient for practical reasons.
Testing errors
Non-ideal tests produce erroneous results, which can be described by a false-negative rate and
a false-positive rate, or equivalently, by giving the test sensitivity and specificity.
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Two sources of errors arise in pooled tests. First, each test that
is performed is inherently non-ideal and may give an error.
These ‘single-test’ errors are described by single-test sensitivity
and specificity. Second, an error may arise if several probes are
mixed together, due to dilution of the material from each
individual. Such ‘dilution errors’ are plausible for large pool
sizes. We advocate small pool sizes (up to five), and at such
small pool sizes no dilution errors have been found in lab studies
[2, 4, 11, 14, 16]. Thus, for our analysis we assume no dilution
errors.
The two-stage testing protocol leads to a modification of the
overall error rates. For the pooled sensitivity, one obtains that
the sensitivity of the pooled test is equal to the square of sensitiv-
ity of a single test. This means that the pooled sensitivity is
reduced, and the number of false negatives increased. The speci-
ficity of the pooled test, on the other hand, is increased compared
with the single test. (See Methods for details.) This means that the
number of false positives is reduced. The reason for this increase
of specificity is, that probes tested positive in the first stage are
tested again in the second stage, thus reducing false positives.
Figure 3 shows, as an example, the improvement of the false-
positive rate compared to single tests.
Methods
When tests from M people are pooled, the pool infection rate p′
(i.e. the probability that a pool is infected) equals p′ = 1− (1− p)M,
where p is the prevalence in the statistical population.
The number of tests performed during the two-stage pooling
protocol (described above) will be denoted by T. Its expectation
value for a statistical population of N individuals with preva-
lence p is E[T ] = N/M + N −N(1 − p)M, while the variance is
Var[T ] = NM((1 − p)M − (1 − p)2M). It is convenient to present
the results in terms of the test ratio t = T/N, which is the ratio
of the number of tests performed with pooling to the number
of tests without pooling. Smaller ratios indicate better perform-
ance of pooling. A plot of the test ratio as a function of the
prevalence, with error bars due to the variance, is shown in
Figure 4.
The optimal pool size has been studied before and the answer
that has been given, e.g. [1, 4], is strongly dependent on the preva-
lence. This, however, is of limited usefulness because (i) the preva-
lence is unknown and (ii) it is unknown which statistical
population is being sampled. Instead we propose to consider
the prevalence itself to be a random variable, drawn from a uni-
form distribution. This amounts to sampling first from a
Fig. 1. Optimal pool size (double-averging model), for
different prevalence ranges.
Fig. 2. Test ratio (number of tests with pooling divided
by number of tests without pooling), for prevalence
range between 0 and pmax. The coloured area indicates
improvement with respect to individual testing.
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population, and then sampling from a population of populations.
Such a model may be not too far from reality. Consider, for
example, one day a lab testing for Covid-19 all people from one
workplace, another day testing travellers returning from a town
and so on. The choice of a uniform distribution for the prevalence
suggests itself because nothing is known; such assumptions are
known as the principle of indifference.
We average the expectation value of the test ratio t = 1/M + 1−
(1− p)M with respect to p, when p is uniformly distributed
between p1 and p2. The resulting test ratio is 〈t〉 = 1/M + 1 +
[(1− p2)M+1− (1 − p1)M+1]/[( p2− p1)(M + 1)]. The results in
Figures 1 and 2 are calculated from this expression.
The test errors can be calculated based on standard formulas
for binary classification tests. We assume no dilution errors (see
above for explanation). This means, for example, that the prob-
ability of obtaining a positive test result for one infected person
is the same as for a pool of M people where at least one person
is infected, even though the pool may contain a different amount
of viral material.
Consider single-test sensitivity s and specificity z. The sensitiv-
ity and specificity of the pooled test is denoted by s′, z′ respect-
ively. Following the two-stage protocol (as described above), one
obtains: s′ = s2. For the specificity, one has the expression
z′ = z + (1− p)M−1z(1− z)+ (1− (1− p)M−1)(1− s)(1− z).
here M≥ 2 is the pool size and p is the prevalence. The specificity
of the pooled test is increased compared to the single-test specifi-
city, as the right-hand side of the expression is always positive.
According to the double-average model, the expression for z′
can be averaged over a uniform distribution of prevalences. This
gives
〈z′〉 = 1− s+ sz
+ [(1− p2)M − (1− p1)M]/[( p2 − p1)M](1− z)(1− s− z).
A plot, for some example values, is shown in Figure 3.
Fig. 3. False-positive ratio for pooled tests, for preva-
lence range between 0 and pmax. The coloured area
indicates improvement with respect to individual test-
ing. Here the individual test s = 90% and specificity z =
99%. Pool size is 4.
Fig. 4. Expected test ratio with pooling (black curve) as
function of prevalence, for pool size M = 4. The coloured
areas indicate the standard error (1σ), for different
number of samples N = 20, 40, 100, 500.
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Conclusions
Pooling of tests allows to increase the test capacity for
Covid-19 testing. For the classic two-stage protocol, a pool
size of four is recommended, based on our model. In the
absence of dilution errors, testing errors reduce the sensitivity
and increase the specificity compared to a test without
pooling.
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